• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

Restricting Dietary Animal Products Improves Metabolism


  • Please log in to reply
No replies to this topic

#1 reason

  • Guardian Reason
  • 1,101 posts
  • 317
  • Location:US

Posted Today, 10:22 AM


Epidemiological evidence for improved health and reduced late life mortality in vegans and vegetarians is both extensive and much debated at the detail level. The study noted here is an interesting addition to this body of work, the researchers having found a sizable population with a long-standing practice of cycling between periods of vegan and omnivorous diets. This produces a more compelling picture of beneficial metabolic changes that take place when animal products are eliminated from the diet. It remains a question as to how much of this is due to a reduced calorie intake in a vegan diet versus other mechanisms.

Dietary interventions constitute powerful approaches for disease prevention and treatment. However, the molecular mechanisms through which diet affects health remain underexplored in humans. Here, we compare plasma metabolomic and proteomic profiles between dietary states for a unique group of individuals who alternate between omnivory and restriction of animal products for religious reasons. We find that short-term restriction drives reductions in levels of lipid classes and of branched-chain amino acids, not detected in a control group of individuals, and results in metabolic profiles associated with decreased risk for all-cause mortality.

We show that 23% of proteins whose levels are affected by dietary restriction are druggable targets and reveal that pro-longevity hormone FGF21 and seven additional proteins (FOLR2, SUMF2, HAVCR1, PLA2G1B, OXT, SPP1, HPGDS) display the greatest magnitude of change. Through Mendelian randomization we demonstrate potentially causal effects of FGF21 and HAVCR1 on risk for type 2 diabetes, of HPGDS on BMI, and of OXT on risk for lacunar stroke. Collectively, we find that restriction-associated reprogramming improves metabolic health and emphasise high-value targets for pharmacological intervention.

Link: https://doi.org/10.1038/s44324-025-00057-2


View the full article at FightAging




3 user(s) are reading this topic

0 members, 3 guests, 0 anonymous users